Sergey Shulyak

Sergey Shulyak is the General Director of DSM Group, a leading analytical and consulting company in the pharmaceutical sector. He has been instrumental in providing insights into market dynamics, especially during the recovery phase post-COVID-19. Under his leadership, the company reported an 11% growth in the pharmaceutical market in 2024, marking a significant rebound from pandemic-induced declines. Shulyak's expertise in market analysis has contributed to understanding trends in drug consumption and distribution in Russia.